Cisen Pharmaceutical Co., Ltd. (SHSE: 603367)
Health Care · Pharmaceuticals · CN
CN¥14.10
-6.87% today · -52.2% 1Y
Cisen Pharmaceutical Co., Ltd. (SHSE: 603367) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $949.64M and employs 3,114 people.
Over the last twelve months the share price has lost 52.2%, trading between 12.13 and 30.50.
Tweenvest scores Cisen Pharmaceutical Co., Ltd. across four factors: quality 74/100, value 46/100, growth 10/100, dividend 59/100. Its strongest factor is quality.
603367 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $949.64M
- Revenue (TTM)
- $489.30M
- P/E
- 15.66
- EPS
- 0.90
- Dividend yield
- 2.27%
- Beta (5Y)
- 0.15
- 52-week high
- CN¥30.50
- 52-week low
- CN¥12.13
- Avg volume (3M)
- —
- Shares outstanding
- 452.75M
- Employees
- 3,114
- Next earnings
- —
About Cisen Pharmaceutical Co., Ltd.
Cisen Pharmaceutical Co., Ltd. operates as a pharmaceutical enterprise, manufacturing and distributing a diverse portfolio of chemical drug preparations and healthcare products to both domestic and international markets. Founded in 1998 and based in Jining, People's Republic of China, the company offers an extensive range of chemical drug solutions. These include medications for liver diseases, antitumor and supportive treatments, nutritional supplements, contrast agents, antibiotics, digestive system remedies, polypropylene ampoules, and topical preparations. Additionally, their product line encompasses sedation and anesthesia agents, cardiovascular drugs, treatments for cough and asthma, immunomodulators, and various infusion and therapeutic infusion products. The company officially changed its name to Cisen Pharmaceutical Co., Ltd. in 2011, having previously operated as Shandong Lukang Cisen Pharmaceutical Co., Ltd.
- ISIN
- CNE100002VG4
- Founded
- 1970
- Listed since
- Sep 29, 2017
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.